Suppr超能文献

尿卟啉原脱羧酶对四吡咯配位的结构基础。

Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase.

作者信息

Phillips John D, Whitby Frank G, Kushner James P, Hill Christopher P

机构信息

Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.

出版信息

EMBO J. 2003 Dec 1;22(23):6225-33. doi: 10.1093/emboj/cdg606.

Abstract

Uroporphyrinogen decarboxylase (URO-D), an essential enzyme that functions in the heme biosynthetic pathway, catalyzes decarboxylation of all four acetate groups of uroporphyrinogen to form coproporphyrinogen. Here we report crystal structures of URO-D in complex with the I and III isomer coproporphyrinogen products. Crystallization required use of a novel enzymatic approach to generate the highly oxygen-sensitive porphyrinogen substrate in situ. The tetrapyrrole product adopts a domed conformation that lies against a collar of conserved hydrophobic residues and allows formation of hydrogen bonding interactions between a carboxylate oxygen atom of the invariant Asp86 residue and the pyrrole NH groups. Structural and biochemical analyses of URO-D proteins mutated at Asp86 support the conclusion that this residue makes important contributions to binding and likely promotes catalysis by stabilizing a positive charge on a reaction intermediate. The central coordination geometry of Asp86 allows the initial substrates and the various partially decarboxylated intermediates to be bound with equivalent activating interactions, and thereby explains how all four of the substrate acetate groups can be decarboxylated at the same catalytic center.

摘要

尿卟啉原脱羧酶(URO-D)是血红素生物合成途径中的一种关键酶,催化尿卟啉原的所有四个乙酸基团脱羧形成粪卟啉原。在此,我们报道了URO-D与I型和III型异构体粪卟啉原产物形成复合物的晶体结构。结晶需要采用一种新颖的酶促方法来原位生成高度氧敏感的卟啉原底物。四吡咯产物呈现出一种圆顶构象,靠在保守疏水残基的环上,并允许不变的Asp86残基的羧酸氧原子与吡咯NH基团之间形成氢键相互作用。对Asp86位点突变的URO-D蛋白进行的结构和生化分析支持了这样的结论:该残基对结合有重要贡献,并可能通过稳定反应中间体上的正电荷来促进催化作用。Asp86的中心配位几何结构允许初始底物和各种部分脱羧的中间体以等效的活化相互作用结合,从而解释了底物的所有四个乙酸基团如何能在同一催化中心脱羧。

相似文献

6
Mutational analysis of human uroporphyrinogen decarboxylase.人尿卟啉原脱羧酶的突变分析
Biochim Biophys Acta. 1996 Dec 5;1298(2):294-304. doi: 10.1016/s0167-4838(96)00148-3.

引用本文的文献

1
Porphyria cutanea tarda: a unique iron-related disorder.迟发性皮肤卟啉症:一种独特的铁相关疾病。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):450-456. doi: 10.1182/hematology.2024000664.
2
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease.《肝性血卟啉病:揭示罕见病的复杂性》
Semin Liver Dis. 2023 Nov;43(4):446-459. doi: 10.1055/s-0043-1776760. Epub 2023 Nov 16.
5
Biosynthesis of the modified tetrapyrroles-the pigments of life.生物合成修饰的四吡咯类化合物——生命的色素。
J Biol Chem. 2020 May 15;295(20):6888-6925. doi: 10.1074/jbc.REV120.006194. Epub 2020 Apr 2.
6
Heme biosynthesis and the porphyrias.血红素生物合成与卟啉病。
Mol Genet Metab. 2019 Nov;128(3):164-177. doi: 10.1016/j.ymgme.2019.04.008. Epub 2019 Apr 22.

本文引用的文献

2
Measurement of uroporphyrinogen decarboxylase activity.尿卟啉原脱羧酶活性的测定
Curr Protoc Toxicol. 2001 May;Chapter 8:Unit 8.4. doi: 10.1002/0471140856.tx0804s00.
3
Raster3D: photorealistic molecular graphics.Raster3D:逼真的分子图形。
Methods Enzymol. 1997;277:505-24. doi: 10.1016/s0076-6879(97)77028-9.
4
Refinement of macromolecular structures by the maximum-likelihood method.用最大似然法优化大分子结构。
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55. doi: 10.1107/S0907444996012255.
5
The CCP4 suite: programs for protein crystallography.CCP4软件包:用于蛋白质晶体学的程序。
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3. doi: 10.1107/S0907444994003112.
7
Crystal structure of human uroporphyrinogen III synthase.人尿卟啉原III合酶的晶体结构
EMBO J. 2001 Nov 1;20(21):5832-9. doi: 10.1093/emboj/20.21.5832.
9
A mouse model of familial porphyria cutanea tarda.迟发性皮肤卟啉病家族性的小鼠模型。
Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):259-64. doi: 10.1073/pnas.98.1.259.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验